Find patient medical information for Insulin Glargine on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings ...

Insulin glargine is not approved by the FDA for use in pregnancy; however, there is currently no insulin with a formal on-label indication for use in pregnancy. Some insulins, ...

Credit: Getty Images. Insulin glargine 300 Units/mL was found to be comparable to insulin glargine 100 Units/mL in providing effective glycemic control in pediatric patients with type 1 diabetes ...

Eli Lilly announced results from a head-to-head study comparing dulaglutide to insulin glargine (Lantus; Sanofi Aventis) for hemoglobin A1c (HbA1C) reduction in patients with type 2 diabetes.The ...

As part of the Biosimilars Initiative, British Columbia, Canada, implemented a mandatory switch to biosimilar insulin glargine for patients covered by the province’s drug plan.

Adding tirzepatide to insulin glargine leads to greater improvements in A1c, body weight, and less hypoglycemia compared with prandial insulin lispro show data simultaneously published in JAMA.

Should glargine be used for diabetics in the intensive care unit? If so, how should it be used? News & Perspective Drugs & Diseases CME & Education Video Decision Point  Specialty: ...

Glargine treatment correlated with greater increases in percentage of time with CGM glucose values ≤3.9 mmol/L, with statistically significant between-group differences at 52 weeks (P < 0.05).

Insulin Glargine (Insulin glargine-yfgn) Injection, 3mL prefilled pens, packaged in cartons of five pens, NDC number 49502-394-75, batch number BF21002895, expires August 2023.

Find patient medical information for Insulin Glargine on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings ...